SI2279159T1 - 2-halobifenil-4-il intermediati v sintezi angiotensin II antagonistov - Google Patents

2-halobifenil-4-il intermediati v sintezi angiotensin II antagonistov

Info

Publication number
SI2279159T1
SI2279159T1 SI200930866T SI200930866T SI2279159T1 SI 2279159 T1 SI2279159 T1 SI 2279159T1 SI 200930866 T SI200930866 T SI 200930866T SI 200930866 T SI200930866 T SI 200930866T SI 2279159 T1 SI2279159 T1 SI 2279159T1
Authority
SI
Slovenia
Prior art keywords
halobiphenyl
angiotensin
antagonists
intermediates
synthesis
Prior art date
Application number
SI200930866T
Other languages
English (en)
Inventor
Anton Copar
Zdenko Casar
Andrej Premrl
Original Assignee
Lek Pharmaceuticals D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP08153085A external-priority patent/EP2103609A1/en
Priority claimed from EP08153084A external-priority patent/EP2103588A1/en
Application filed by Lek Pharmaceuticals D.D. filed Critical Lek Pharmaceuticals D.D.
Publication of SI2279159T1 publication Critical patent/SI2279159T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/26—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/263—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • C07C17/14—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms in the side-chain of aromatic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/26—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/263—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions
    • C07C17/2632—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions involving an organo-magnesium compound, e.g. Grignard synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Catalysts (AREA)
SI200930866T 2008-03-20 2009-03-19 2-halobifenil-4-il intermediati v sintezi angiotensin II antagonistov SI2279159T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP08153085A EP2103609A1 (en) 2008-03-20 2008-03-20 Catalyzed carbonylation in the synthesis of angiotensin ii antagonists
EP08153084A EP2103588A1 (en) 2008-03-20 2008-03-20 2'-Halobiphenyl-4-yl intermediates in the synthesis of angiotensin II antagonists
EP09723165.8A EP2279159B1 (en) 2008-03-20 2009-03-19 2'-halobiphenyl-4-yl intermediates in the synthesis of angiotensin ii antagonists
PCT/EP2009/053267 WO2009115584A2 (en) 2008-03-20 2009-03-19 2'-halobiphenyl-4-yl intermediates in the synthesis of angiotensin ii antagonists

Publications (1)

Publication Number Publication Date
SI2279159T1 true SI2279159T1 (sl) 2014-04-30

Family

ID=40647168

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200930866T SI2279159T1 (sl) 2008-03-20 2009-03-19 2-halobifenil-4-il intermediati v sintezi angiotensin II antagonistov

Country Status (10)

Country Link
US (2) US8445693B2 (sl)
EP (2) EP2279159B1 (sl)
JP (2) JP5764055B2 (sl)
CN (2) CN102036937B (sl)
CA (2) CA2718891C (sl)
ES (1) ES2450370T3 (sl)
PL (1) PL2279159T3 (sl)
PT (1) PT2279159E (sl)
SI (1) SI2279159T1 (sl)
WO (2) WO2009115584A2 (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8445693B2 (en) * 2008-03-20 2013-05-21 Lek Pharmaceuticals D.D. Catalyzed carbonylation in the synthesis of angiotensin II antagonists
JP5711888B2 (ja) * 2010-01-26 2015-05-07 株式会社Ｄｎｐファインケミカル宇都宮 テルミサルタンアルキルエステルの製造法
EP2632438A1 (en) 2010-10-27 2013-09-04 KRKA, tovarna zdravil, d.d., Novo mesto Multilayer pharmaceutical composition comprising telmisartan and amlodipine
CN103333204B (zh) * 2013-07-12 2016-01-20 河南省科学院化学研究所有限公司 一类9,9’-螺二芴衍生物的合成方法
US9783476B2 (en) * 2014-09-19 2017-10-10 Toray Fine Chemicals Co., Ltd. Method of producing 2′-trifluoromethyl group-substituted aromatic ketone
CN114436833A (zh) * 2021-12-27 2022-05-06 南京红太阳医药研究院有限公司 一种替米沙坦关键中间体4′-甲基联苯-2-羧酸酯的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
SI9210098B (sl) * 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
EP0649424B1 (en) * 1992-07-10 1998-10-07 Knoll AG Dioxcyclobutene derivatives as angiotensin ii antagonists
JP3261474B2 (ja) * 1992-09-22 2002-03-04 株式会社ジェムコ ２−クロロ−４，５−ジフルオロ安息香酸の製造法
US5606107A (en) * 1995-06-07 1997-02-25 Monsanto Company Formic acid and formaldehyde destruction in waste streams
JP4001665B2 (ja) * 1997-09-24 2007-10-31 株式会社ヤクルト本社 発酵製品の培養管理方法
JP4573409B2 (ja) * 2000-08-10 2010-11-04 Ａｇｃセイミケミカル株式会社 光学活性化合物、それを含有する液晶組成物および液晶素子
DE10314702A1 (de) * 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von Telmisartan
MX2007004426A (es) * 2004-10-15 2007-06-14 Teva Pharma Procesos para preparar telmisartan.
US7968727B2 (en) 2005-04-01 2011-06-28 Lek Pharmaceuticals, D.D. Synthesis of 4-bromomethyl-2′-formylbiphenyl and 4-bromomethyl-2′-hydroxymethylbiphenyl and its use in preparation of angiotensin II antagonists
ITMI20050801A1 (it) * 2005-05-03 2006-11-04 Dipharma Spa Procedimento per la preparazione di telmisartan
US8445693B2 (en) * 2008-03-20 2013-05-21 Lek Pharmaceuticals D.D. Catalyzed carbonylation in the synthesis of angiotensin II antagonists

Also Published As

Publication number Publication date
CA2719068A1 (en) 2009-09-24
JP2011515374A (ja) 2011-05-19
US20110098329A1 (en) 2011-04-28
EP2279185B1 (en) 2014-01-15
CA2718891A1 (en) 2009-09-24
WO2009115584A3 (en) 2009-11-12
EP2279159A2 (en) 2011-02-02
JP5764055B2 (ja) 2015-08-12
WO2009115585A1 (en) 2009-09-24
CN102036937B (zh) 2014-06-04
EP2279185A1 (en) 2011-02-02
ES2450370T3 (es) 2014-03-24
PL2279159T3 (pl) 2014-05-30
CA2718891C (en) 2016-10-18
JP5462857B2 (ja) 2014-04-02
CN102015690B (zh) 2014-04-30
CN102036937A (zh) 2011-04-27
CN102015690A (zh) 2011-04-13
US20110105539A1 (en) 2011-05-05
JP2011515373A (ja) 2011-05-19
EP2279159B1 (en) 2013-12-04
US8410285B2 (en) 2013-04-02
US8445693B2 (en) 2013-05-21
PT2279159E (pt) 2014-03-10
WO2009115584A2 (en) 2009-09-24
CA2719068C (en) 2016-10-11

Similar Documents

Publication Publication Date Title
ZA201006127B (en) 4'4'-dioxaspiro-spirocyclically substituted tetramates
IL210834A0 (en) Cyclohexyl amide derivatives and their use as crf-1 receptor antagonists
ZA201107336B (en) Synthesis of 2'-o-fucosyllactose
HK1203980A1 (en) Il-17ra-il-17rb antagonists and uses thereof il-17ra-il-17rb
ZA200906812B (en) Crig antagonists
ZA201105056B (en) 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
IL199430A0 (en) Crth2 antagonists
EP2245315A4 (en) "O" head-EXECUTION
BR112012003701A2 (pt) "novos antagonistas de quinolina-hepcidina"
IL210650A0 (en) Rna antagonists targeting gli2 and uses thereof
IL201874A0 (en) Azetidine derivatives and their use as prostaglandin e2 antagonists
SI2279159T1 (sl) 2-halobifenil-4-il intermediati v sintezi angiotensin II antagonistov
ZA200904479B (en) Nitroderivatives as angiotensin II receptor antagonists
ZA201002171B (en) 2-s-benzyl substituted pyrimidines as crth2 antagonists
PL2242491T3 (pl) Nowatorskie zastosowanie 3,3'-diinodolilometanu
GB0817646D0 (en) Ace's PC1
HUE041624T2 (hu) 2'-Ciano-2'-dezoxi-N4-palmitoil-1-beta-D-arabinofuranozilcitozin szintézisében alkalmazható intermedierek elõállítása
GB0920294D0 (en) "Limpet" multi-purpose post anchor
HK1146065A1 (en) Nlrr-1 antagonists and uses thereof nlrr-1
GB2451897B (en) "No-bend" pet-feeding aid
GB0822289D0 (en) "BABOO"babyseat carry
KZ22885A4 (en) Toothpaste "Benta"
GB0707985D0 (en) Easy's
GB0717956D0 (en) 20's
PL385440A1 (pl) Sposób wytwarzania 4'-O- -D-glukozylo-2',4-dihydroksy-6'-metoksy-3'-prenylochalkonu